Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease
- 1 November 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 7 (10), 769-779
- https://doi.org/10.1016/j.crohns.2013.01.009
Abstract
The clinical introduction of tumour necrosis factor (TNF) inhibitors has deeply changed the treatment of inflammatory bowel diseases (IBD). It has demonstrated impressive efficacy as compared to alternative treatments, allowing for the chance to achieve near-remission and long-term improvement in function and quality of life and to alter the natural history of Crohn's disease (CD) and ulcerative colitis (UC). As a consequence of longer follow-up periods the number of side effects which may be attributed to treatment with biologics is growing significantly. Cutaneous reactions are among the most common adverse reactions. These complications include injection site reactions, cutaneous infections, immune-mediated complications such as psoriasis and lupus-like syndrome and rarely skin cancers. We review the recent literature and draw attention to dermatological side effects of anti-TNF therapy of inflammatory bowel disease.Keywords
This publication has 108 references indexed in Scilit:
- Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non‐melanoma skin cancer in an at‐risk population: A cohort studyJournal of Gastroenterology and Hepatology, 2012
- Psoriasis associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literatureAlimentary Pharmacology & Therapeutics, 2011
- Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2009
- Dermatological complications and safety of anti-TNF treatmentsGut, 2009
- Genital HPV Lesions and Molluscum Contagiosum Occurring in Patients Receiving Anti-TNF-α TherapyDermatology, 2008
- Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsAnnals Of The Rheumatic Diseases, 2007
- Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studiesArthritis & Rheumatism, 2007
- Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonistsBritish Journal of Dermatology, 2007
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Genital condylomata in a patient receiving infliximab for Crohn’s diseasePublished by Oxford University Press (OUP) ,2004